SSO is pleased to announce the availability of two Young Investigator Awards for the 2025 cycle:
- An any topic Young Investigator Award (supported by SSO);
- A second Young Investigator Award-Appendix Cancer Pseudomyxoma Peritonei (PMP) (supported by a grant from the Appendix Cancer Pseudomyxoma Peritonei Research Foundation).
- For proposals related to appendiceal mucinous neoplasms, appendiceal adenocarcinomas (including signet ring cell adenocarcinoma and goblet cell adenocarcinoma), and/or PMP of appendiceal origin; with a special interest in proposals that embrace moving this rare malignant tumor type forward to a curative science.
The Young Investigator Awards promote and recognize clinical and translational research that advance innovative ideas and concepts designed to improve health outcomes through advances in the delivery of cancer-related care. Awards are given for up to $25,000 for one year, beginning May 1 of the award year and concluding April 30 of the following year. The award is non-renewable. Applicants may apply more than once but may only receive the award one time.